Compugen Ltd.  Banner Image

Compugen Ltd.

  • Ticker CGEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Compugen Ltd.  Logo Image
  • 51-200 Employees
  • Based in Holon, Israel
Compugen is a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology. The Company utilizes a broad and continuously growing integrated infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biologyMore capabilities for the in silico (by computer) prediction and selection of product candidates, which are then advanced in its Pipeline Program. The Company's business model includes collaborations covering the further development and commercialization of product candidates at various stages from its Pipeline Program and various forms of research and discovery agreements, in both cases providing Compugen with potential milestone payments and royalties on product sales or other forms of revenue sharing. Compugen’s wholly-owned U.S. subsidiary located in South San Francisco is developing monoclonal antibody therapeutic candidates against its drug targets.
4.8 / 5.0 (149)

Compugen Ltd. reports have an aggregate usefulness score of 4.8 based on 149 reviews.

Compugen Ltd.

Most Recent Annual Report

Compugen Ltd.
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Compugen Ltd.  Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!